Senior Manager/ Manager, Regional Segment Marketing

Shanghai, China

Apply with AI Apply

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Genomic Technology, Biotechnology, HealthcareIndustries

Requirements

Candidates must have 7+ years of experience in marketing, sales, and/or technology within the life sciences or related industries. A strong understanding of genetics technologies and their application in genetic disease or multiomics is required, along with excellent communication, presentation, and negotiation skills. Fluency in both English and Chinese (verbal and written) is essential. A university/college degree in a scientific discipline is required, with a Master's or PhD degree being an advantage.

Responsibilities

The Senior Regional Segment Marketing Manager will develop market opportunities by assessing market dynamics, understanding customer needs, and building relationships with key stakeholders. This role involves implementing go-to-market strategies, creating compelling messaging and positioning, generating demand, and enabling the sales team through training and tools. Responsibilities include acting as the primary regional contact for Illumina technologies in Multi-omics solutions, consolidating regional market insights, leading marketing campaigns and product launches, executing promotional activities, coordinating local events, and assisting the sales team to achieve targets.

Skills

Market Analysis

Customer Requirements

Stakeholder Relationships

Go-to-Market Strategy

Messaging and Positioning

Demand Generation

Multi-omics Solutions

Market Dynamics

Campaign Planning

Product Launches

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

San Diego, CaliforniaHeadquarters

1998Year Founded

$27.2MTotal Funding

IPOCompany Stage

Venture Capital, BiotechnologyIndustries

5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.

Standardizing proteomics data across platforms could challenge Illumina's data reliability.

Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.

The company offers innovative array-based solutions for DNA, RNA, and protein analysis.

Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.

Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.

Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI

Try Jobo Free